approval
saveBKEMV (ECULIZUMAB-AEEB) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMar 26, 2026 · 198d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalNov 24, 2025 · 320d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalSep 17, 2025 · 388d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalJan 30, 2025 · 618d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalOct 23, 2024 · 717d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMay 28, 2024 · 865d ago
same company · ±60 days · 5
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalApr 29, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 7, 2025
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalMay 20, 2025
comments(0)
5-min edit window · permanent after that